Legal Marijuana

Legal Marijuana Market Size To Surge Past US$ 65.1 Billion By 2027, study by Precedence Research.


The legal marijuana market size is estimated to reach US$ 65.1 billion by the end of 2027, registering a CAGR of 17.8% from 2020 to 2027. The report provides the overall revenue of the global legal marijuana market from 2016 to 2027, considering 2020 as the base year and 2027 as the forecast year.

Marijuana also known as cannabis is a brown, green or gray mix of shredded, dried leaves, seeds, stems and flowers of the hemp plant named Cannabis sativa. It is employed as a mind altering or psychoactive recreational drug for particular medical ailments, for spiritual and divine purposes. The cannabis industry involves legal operations regarding marijuana and hemp which is its non-intoxicating cousin.

Medical marijuana means application of cannabis as a physician suggested therapy for treatment of some health circumstances and symptoms. It is widely utilized for treating mental disorders, chronic pain conditions and diseases, arthritis, cancer treatment, migraine, and other medical situations. The indication for the legitimate medical application of cannabinoids or marijuana is limited to few indications, notably nausea or vomiting, HIV/AIDS cachexia, connected to neuropathic pain, chemotherapy, and spasticity in multiple sclerosis. These medical applications are stimulating the growth of legal marijuana market across the world. Marijuana legalization is a provocative and complicated issue that is nowadays the subject of thoughtful debate. Since 2012, 4 U.S. states have approved ballot initiatives to eliminate ban and authorize a for-profit commercial marijuana business.

We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @

Growth Factors

Marijuana is becoming legal in cumulative number of states for both recreational and medical and application. Substantial disagreement present concerning the public health influence of these fluctuations. Rising number of research studies to discover innovative therapeutic uses will accelerate the medical marijuana market advancement in North America. However, non-uniformity and irregularities of cannabis testing standards will hinder market growth. Besides, deficiency of consciousness among the emergent nations plus lack of sufficient safety data will further restrict the growth of medical marijuana market. Though the market for cannabis is anticipated to experience substantial growth over the impending years, crop pricing might extremely hinder development of cannabis market. This might occur as more nations around the world look forward to commoditizing cannabis, that may lead downward trend for crop prices.

Report Highlights

  • Despite growing acceptance of cannabis application across the globe, marijuana remains taboo and outlawed in most parts of Asia Pacific mostly on account of stigma neighboring it.
  • North America grasp substantial revenue stake share in 2019 on account of growing popularity and adoption in growth in the U.S. and Canadian markets
  • Europe medical cannabis market is predicted to witness substantial growth during estimate timeframe.

Regional Snapshots

The advancement of North America medical marijuana sector is mostly supported by swelling need of medical cannabis for the treatment of numerous health conditions. Also, awareness programs directed by private and public associations and cumulative number of states legalizing medical application of cannabis will push business progress. For example, since 2014, 13 states in the U.S. legitimate the medical practice of cannabis. The legalization has boosted the need from both medical and recreational consumers.

Countries such as the U.S. and Canada, where adult application of marijuana has been legalized, have perceived a dynamic modification from patients electing for recreational cannabis than medical. This can be credited to the extensive variety, easy obtainability, and low prices. In nations where repayment for medical cannabis is not significant, this change in trend is much evidentiary. Since 1985, cannabis has been prohibited in China. Yet, species of cannabis named hemp is still grown in the nation and factually has been employed for fibre also ritual purposes inside Taoism. Furthermore, Thailand became the first nation in Southeast Asia to authorize consumption and growth of medical marijuana and started its first legal cannabis greenhouse in 2019.

Key Players & Strategies

Vigorous growth in the global demand for cannabis has pushed the necessity to come up with improved product delivery systems also maintainable product strains. This need has thus stimulated various companies coming up with research and development which broadly examines numerous genetic improvement tactics for cannabis. For example, in March 2018, Hydropothecary collaborated with Segra to integrate plant tissue propagation in the cannabis plant production procedure, to aid surge the produce of healthier variant plants to meet the budding industry for recreational and medical cannabis.

Few notable players operating in the industry are Aurora Cannabis, Inc., Aphria, Inc Emerald Health Therapeutics Inc., Canopy Growth Corporation, and mCig, Inc among other. These participants are executing numerous strategies like novel product introduction, alliances, in order to grab high revenues take in medical marijuana sector. In 2015, Otsuka Pharmaceuticals and GW Pharmaceuticals publicized results of 3 US Phase 3 trials for the practice of Sativex for the pain management treatment in patients with advanced cancer who experience insufficient analgesia throughout optimized chronic opioid therapy.

Segments Covered in the Report

This research report includes complete assessment of the market with the help of extensive qualitative and quantitative insights, and projections regarding the market. This report offers breakdown of market into prospective and niche sectors. Further, this research study calculates market revenue and its growth trend at global, regional, and country from 2016 to 2027. This report includes market segmentation and its revenue estimation by classifying it on the basis of end-use and region as follows:

By Marijuana Type

  • Medical
  • Adult Use

By Product Type

  • Oils
  • Buds
  • Tinctures

By Application

  • Mental Disorders
  • Chronic Pain
  • Cancer
  • Others

By Regional

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Why Buy this Report?

The purpose of Precedence Research’s legal marijuana market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.

Buy Full Research Report (Single User License US$ 4500) @

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace &defense, among different ventures present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333



Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. Email:

View all posts by Precedence Research →

Leave a Reply

Your email address will not be published. Required fields are marked *